Clinical Trial Update: Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating GAAD score plus AFP/PIVKA-II or ultrasound for surveillance of people at risk for hepatocellular carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatitis C
• Hepatocellular Carcinoma
• Liver Cirrhosis

Snippet

Sponsor: Siriraj Hospital | Conditions: Liver Cirrhosis, Hepatitis B, Chronic | NA | Status: ENROLLING_BY_INVITATION